1.Stoesser, N et al. (2016) Evolutionary history of the global emergence of the Escherichia coli epidemic clone ST131. mBio 7, e02162–15.
2.Nicolas-Chanoine, M-H, Bertrand, X and Madec, J-Y (2014) Escherichia coli ST131, an intriguing clonal group. Clinical Microbiology Reviews 27, 543–574.
3.Banerjee, R et al. (2013) Molecular epidemiology of Escherichia coli sequence type 131 and its H30 and H30-Rx subclones among extended-spectrum-beta-lactamase-positive and -negative E. coli clinical isolates from the Chicago region, 2007 to 2010. Antimicrobial Agents and Chemotherapy 57, 6385–6388.
4.Can, F et al. (2015) Emerging Escherichia coli O25b/ST131 clone predicts treatment failure in urinary tract infections. Clinical Infectious Diseases 60, 523–527.
5.Clinical and Laboratory Standards Institute (2013) Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Third Informational Supplement. Wayne, PA: Clinical and Laboratory Standards Institute.
6.Johnson, JR et al. (2014) Rapid and specific detection, molecular epidemiology, and experimental virulence of the O16 subgroup within Escherichia coli sequence type 131. Journal of Clinical Microbiology 52, 1358–1365.
7.Müller, A, Stephan, R and Nüesch-Inderbinen, M (2016) Distribution of virulence factors in ESBL-producing Escherichia coli isolated from the environment, livestock, food and humans. Science of the Total Environment Elsevier B.V. 541, 667–672.
8.Blanco, J et al. (2011) National survey of Escherichia coli causing extraintestinal infections reveals the spread of drug-resistant clonal groups O25b:H4-B2-ST131, O15:H1-D-ST393 and CGA-D-ST69 with high virulence gene content in Spain. Journal of Antimicrobial Chemotherapy 66, 2011–2021.
9.Colpan, A et al. (2013) Escherichia coli sequence type 131 (ST131) subclone H30 as an emergent multidrug-resistant pathogen among US veterans. Clinical Infectious Diseases 57, 1256–1265.
10.Price, LB, Johnson, JR and Aziz, M (2013) The epidemic of extended-spectrum-β-lactamase-producing Escherichia coli ST131 is driven by a single highly pathogenic subclone, H30-Rx. mBio 4, e00377–13.